Published date: 9 August 2024

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 11 October 2024, 12pm

Contract summary

Industry

  • Health services - 85100000

Location of contract

United Kingdom

Value of contract

£2,760,000

Procurement reference

CF-2533200D0O000000rwimUAA

Published date

9 August 2024

Closing date

11 October 2024

Closing time

12pm

Contract start date

1 May 2025

Contract end date

30 April 2027

Contract type

Service contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No


Description

This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities


More information

Additional text

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: support-health@atamis.co.uk


About the buyer

Contact name

Jane Brailsford

Address

Florence Nightingale Community Hospital, London Road
Derby
DE1 2QY
GB

Email

jane.brailsford1@nhs.net